Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

v3.4.0.3
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
3 Months Ended 9 Months Ended
Mar. 31, 2016
Mar. 31, 2015
Mar. 31, 2016
Mar. 31, 2015
Net revenue $ 117,000 $ 199,000 $ 394,000 $ 495,000
Cost of sales 327,000 220,000 767,000 492,000
Gross (loss) profit (210,000) (21,000) (373,000) 3,000
Operating expenses:        
Selling and administrative expenses 588,000 498,000 1,746,000 1,447,000
Amortization of prepaid advisory fees 7,000 2,000 19,000 35,000
Research and development 253,000 137,000 1,048,000 399,000
Total operating expenses 848,000 637,000 2,813,000 1,881,000
Operating loss (1,058,000) (658,000) (3,186,000) (1,878,000)
Other income (expense):        
Change in fair value of derivative liabilities 16,000 60,000 16,000 498,000
Interest expense (190,000) (42,000) (286,000) (65,000)
Other income (expense) 0 8,000 0 (2,000)
Net loss $ (1,232,000) $ (632,000) $ (3,456,000) $ (1,447,000)
Net loss per share - basic and diluted $ (0.01) $ (0.01) $ (0.02) $ (0.02)
Weighted average number of common shares outstanding - basic and diluted 150,901,345 99,384,111 138,710,894 96,861,970